Document:

Exhibit 10.2

 

	 	CERTIFICATE

No. _________

 

 

 

  

STOCK OPTION CERTIFICATE

This
Stock Option is granted by 

ANGION
BIOMEDICA CORP.

to

Name:[_____________] ("Optionee")

 

Address: [_______________]

      [_______________]

 

in accordance with and pursuant
to the terms of the 2002 Stock Option Plan (the "Plan") of ANGION BIOMEDICA CORP., a Delaware corporation (the
"Company").

 

The terms of the Plan are incorporated
by reference and shall be considered to be a part of this Stock Option Certificate. A copy of the Plan is attached hereto as Exhibit
A.

 

The terms of the Stock Option granted to you include
the following:

 

1.          Grant.On
[_________], the Board of Directors of the Company granted to the Optionee an Incentive Stock Option (the "Stock Option")
to purchase all or any part of an aggregate of [__________] ([______]) shares (the "Option Shares") of the Common Stock,
$0.01 value (the "Common Stock"), of the Company, at an exercise price of $[______] per share, subject to adjustment
in accordance with the terms and conditions set forth in the Plan.

 

2.          Vesting;
Termination. 2.1 This Stock Option shall expire at 5:00 p.m., New York time, on [___________], subject to earlier termination
as provided in the Plan. The Stock Options shall be exercisable only to the extent the Optionee is vested therein. This Stock Option
shall vest and be exercisable (provided the Optionee is then in the employ or service of the Company or is otherwise eligible as
provided in the Plan) in whole or in part as to the following number of Option Shares (subject to adjustment in accordance with
Section 12 of the Plan):

 

	Number of Total Option Shares	When Option Shares Become Exercisable
	[_____]	[__________]
	[_____]	[__________]
	[_____]	[__________]
	[_____]	[__________]

2.2 Upon an event of a Change
of Control of the Company (as defined in Section 8.4 of the Plan), all Option Shares not yet vested and exercisable shall immediately
vest and become exercisable to the extent otherwise provided for in this Certificate.

    	1

    	 

    

3.          Exercise Procedure This Stock Option may be exercised by giving written notice to the
Company in the form attached hereto as Exhibit B stating the number of Option Shares to be purchased and by concurrently
tendering payment by check or wire transfer. Upon exercise and payment, and the Optionee entering into a Stockholders Agreement
with respect to the Option Shares, the stock certificate for the purchased Option Shares shall be issued within five (5) business
days as fully-paid and non-assessable shares of the Common Stock of the Company.

 

4.          Rights.  The Optionee shall not have any rights to dividends, voting or other rights of a stockholder
with respect to any Option Shares until a stock certificate for such Option Shares shall have been issued to the Optionee. The
Optionee acknowledges the grant of the Option herein does not confer on the Optionee any rights with respect to the continuation
of the Optionee's employment with the Company or to interfere with the right of the Company to terminate such employment, which
employment is subject to a separate Employment, Confidential Information and Invention Assignment Agreement between the Optionee
and the Company (the "Employment/Confidential Agreement").

 

5.          Non-Transferable.  This Certificate and the Stock Option granted herein are not transferable
by the Optionee, and shall be exercised only by the Optionee. Any transfer in violation of this Section may, at the Company's discretion
result in the termination of the Option and cancellation of the unexercised Option Shares.

 

6.          Entire Agreement. This Certificate and the Plan constitute the entire agreement
between the Optionee and the Company with respect to the Option granted herein, and supersedes any prior agreement (written or
oral) as to the subject matter herein; however, this Certificate shall not affect the Employment/Confidential Agreement

 

7.          Binding.  This Certificate and the Plan shall be binding upon the Company and the Optionee
with respect to the Option herein.

 

8.          Governing Law.  This Certificate shall be governed by and constituted in accordance
with the laws of the State of Delaware without giving effect to principles of conflicts of law.

 

IN WITNESS WHEREOF, Angion Biomedica
Corp. has hereunto set its hand on the [_____] day of [_________, ____]

 

 

ANGION BIOMEDICA CORP.

 

By:

Name:___________________

Title: ___________________

 

 

Agreed to:

 

 

____________________________

  [_____________________]

 

    	2Exhibit 10.10

 

ANGION BIOMEDICA CORPORATION

 

EMPLOYEE CONFIDENTIAL INFORMATION AND

INVENTION ASSIGNMENT AGREEMENT

 

As a condition of my employment
with Angion Biomedica Corporation (“Angion”), and in consideration of my employment with Angion and my receipt of the
compensation now and hereafter paid to me by Angion, I agree to the following:

 

1.           Confidential
Information. 

 

(a) Angion and Third Party Information.
I agree at all times during the term of my employment and thereafter, to hold in strict confidence, and not to use, except for
the benefit of Angion, or to disclose to any person, firm or corporation without written authorization of an officer of Angion,
any Confidential information. I understand that “Confidential Information” means any confidential or proprietary information,
technical data, trade secrets or know-how of Angion, including, but not limited to, research and product plans, products, services,
customer lists and customers, markets, developments, inventions, processes, formulas, technology, marketing, finances or other
business information disclosed to me by Angion, either directly or indirectly, in writing, orally or otherwise. I recognize that
Angion has received and in the future will receive from third parties confidential or proprietary information of such third parties
subject to a duty on Angion’s part to maintain the confidentiality of such information and to use such information only
for certain limited purposes, and I understand that such information is also Confidential Information. I further understand that
Confidential Information does not include any of the foregoing information or items that has become publicly known and made generally
available through no wrongful act of mine or of others who were under confidentiality obligations to Angion as to the information
or items involved.

 

(b) Former Employer information.
I agree that I will not, during my employment with Angion, improperly use or disclose any proprietary information or trade secrets
of any former or concurrent employer or other person or entity and that I will not bring onto the premises of Angion any unpublished
document or proprietary information belonging to any such employer, person or entity unless consented to in writing by such employer,
person or entity.

 

2.            Inventions.

 

(a) Inventions Retained and Licensed.
I have attached hereto as Attachment A a list describing all inventions, original works of authorship, developments, improvements,
and trade secrets that were made by me prior to my employment with Angion (collectively referred to as “Prior Inventions”),
that belong to me, that relate to Angion’s business, products or research and development, and that are not assigned to
Angion hereunder; or, if no such list is attached, I represent that there are no such Prior Inventions. If in the course of my
employment with Angion, I incorporate into an Angion product, process or machine a Prior Invention owned by me or in which I have
an interest, Angion is hereby granted and will have a non-exclusive, royalty free, irrevocable, perpetual, worldwide license,
with the right to grant sublicenses, to

 

    	1

    	 

    

 

make, have made, modify, use and
sell such Prior Invention as part of or in connection with such product, process or machine.

 

(b)          Assignment
of Inventions. I agree that I will promptly make full written disclosure to Angion, and will hold in trust for the sole
right and benefit of Angion, and hereby assign to Angion, or Angion’s designee, all my right, title, and interest in and to
any and all inventions, original works of authorship, developments, concepts, improvements or trade secrets, whether or not
patentable or registrable under patent, copyright or similar laws that I may solely or jointly make, develop, conceive or
reduce to practice, or cause to be made, developed, conceived or reduced to practice, during the period of time I am in the
employ of Angion, (collectively referred to as “Inventions”). I further acknowledge that all original works of
authorship that are made by me (solely or jointly with others) within the scope of and during the period of my employment
with Angion and that are protectable by copyright are “works made for hire,” as that term is defined in the United
States Copyright Act and shall be owned by Angion.

 

(c)          Maintenance
of Records. I agree to keep and maintain adequate and current written records of all Inventions made, developed, conceived
or reduced to practice by me (solely or jointly with others) during the term of my employment with Angion. The records will be
in the form of notes, sketches, drawings, laboratory notebooks, and any other format that may be specified by Angion. The records
will be available to and remain the sole property of Angion at all times.

 

(d)          Patent and Copyright Registrations.
I agree to assist Angion, or Angion’s designee, at Angion’s expense, in every way to secure Angion’s rights in the Inventions and
any copyrights, patents, mask work rights or other intellectual property rights relating thereto in any and all countries, including
disclosing to Angion all pertinent information and data with respect thereto, and executing all applications, specifications, oaths,
assignments and all other instruments that Angion shall deem necessary in order to apply for and obtain such rights and in order
to assign and convey to Angion, Angion’s successors, assigns and nominees the sole and exclusive rights, title and interest in
and to such Inventions, and any copyrights, patents, mask work rights or other intellectual property rights relating thereto. I
further agree that my obligation to execute or cause to be executed, when it is in my power to do so, any such instrument or papers
will continue after the termination of this Agreement. If Angion is unable because of my mental or physical incapacity or for any
other reason to secure my signature to apply for or to pursue any application for any United States of America or foreign patents
or copyright registrations covering Inventions or original works or authorship assigned to Angion as above, then I hereby irrevocably
designate and appoint Angion and Angion’s duly authorized officers and agents as my agent and attorney in fact, to act for and
in my behalf and stead to execute and file any such applications and to do all other lawfully permitted acts to further the prosecution
and issuance of letters patent or copyright registrations; thereon with the same legal force and effect as if executed by me.

 

3.           Conflicting
Employment.

 

I agree that, during the term of my employment
with Angion, I will not engage in any other employment, occupation, consulting or other business activity directly related to the
business in which Angion is now involved or becomes involved during the term of my

 

    	2

    	 

    

 

employment, nor will I
engage in any other activities that conflict with my obligations to Angion.

 

4.           Returning
Angion Property.

 

I agree that, at the time of
leaving the employ of Angion, I will deliver to Angion (and will
not keep in my possession, recreate or deliver to anyone else) any and all documents or property, or reproductions of any such
documents or property, developed by me pursuant to my employment with Angion or otherwise belonging to Angion, its successors or
assigns.

 

5.           Solicitation
of Employees.

 

I agree that for a period of
twelve (12) months immediately following the termination of my employment relationship with Angion for any reason, whether with
or without cause, I will not either directly or indirectly solicit,
induce, recruit or encourage any of Angion’s employees to leave Angion employment, or take away such employees, or attempt to solicit,
induce, recruit, encourage or take away employees of Angion, either for myself or for any other person or entity.

 

6.           Representations.

 

I agree to execute any proper
oath or verify any proper document or perform any other act seemed necessary or desirable as requested by Angion to carry out the
term of this Agreement. I represent that my performance of all
the terms of this Agreement will not breach any agreement to keep in confidence proprietary information acquired by me in confidence
or in trust prior to my employment by Angion. I have not entered
into, and I agree I
will not enter into, any oral or written agreement in conflict with the terms of this Agreement. I
understand my obligations in sections 1, 2, 4, 5 and 7 survive the termination of my employment with Angion.

 

7.            Arbitration-and
Equitable Relief.

 

(a)          Arbitration.
Except as provided in Section 7 (b) below, I agree that any dispute
or controversy arising out of or relating to any interpretation, construction, performance or breach of this Agreement, will be
settled by arbitration to be held in New York City, NY, in accordance with the rules then in effect of the American Arbitration
Association. The arbitrator may grant injunctions or other relief in such dispute or controversy. The decision of the arbitrator
will be final, conclusive and binding on the parties to the arbitration. Judgment may be entered on the arbitrator’s decision in
any court having jurisdiction. Angion and I will each pay one-half
of the costs and expenses of such arbitration, and each of us will separately pay our counsel and witness fees and expenses.

 

(b)          Equitable
Remedies. I agree that it would be impossible or
inadequate to measure and calculate Angion’s damages from any breach of the covenants set forth in Sections 1, 2, 4 and 5
herein. Accordingly, I agree that if I breach my obligations
under any of such sections, Angion will have, in addition to any other right or remedy available, the right to seek an
injunction from a court of competent jurisdiction restraining such breach or threatened breach

 

    	3

    	 

    

 

and to specific performance of any such provision
of this Agreement. I further agree that no bond or other security will be required in obtaining such equitable relief.

 

8.           General
Provisions.

 

(a)          Governing
Law. This Agreement will be governed by the laws of the State of New York without reference to conflicts of laws principles.

 

(b)          Entire
Agreement. This Agreement sets forth the entire agreement and understanding between Angion and me relating to the subject matter
hereof and merges all prior discussions between us. No modification of or amendment to this Agreement, or any waiver of any rights
under this Agreement, will be effective unless in writing signed by the party to be charged. Any subsequent change or changes in
my duties, salary or compensation will not affect the validity or scope of this Agreement.

 

(c)          Severability.
If one or more of the provisions in this Agreement are deemed void by law, then he remaining provisions will continue in full
force and effect.

 

(d)          Successors
and Assigns. This Agreement will be binding upon my heirs, executors, administrators and other legal representatives and will
be for the benefit of Angion, its successors, and its assigns.

 

Date:    1/1/2005

 

	Signature:	/s/ Itzhak D. Goldberg	 
	 	 	 
	Name of Employee:	Itzhak D. Goldberg

	 
	 	 	 
			 
	 	 	 
	Angion Biomedica Corp. “Angion”	 
	 	 	 
	Signature:	/s/ Itzhak D. Goldberg	 
	 	 	 
	Name:	Itzhak D. Goldberg	 
	 	 	 
	Title:	CEO	 

 

    	4

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00229-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00229-of-00352.parquet"}]]